Summary
- Current Price
- As of today, MRKR price is $1.45, up +1.40% on
- Current Price All-Time High
- MRKR price is currently -100.00% below its historical high of $6,120,000.00 set on
- Market Cap
- MRKR current market cap is $19M, up +1.86% over the past 365 days
- PE Ratio
- MRKR PE ratio is unknown
- Revenue
- MRKR current annual revenue is $6.59M, up +99.06% year-over-year
- Next Earnings
- As of today, the next earnings release for MRKR has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Marker Therapeutics, Inc. |
| Ticker | NASDAQ: MRKR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | markertherapeutics.com |
| Employees | 5 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.45 | ||
| Price, 1D Change | +1.40% | |
| $19M | ||
| - | ||
| - | ||
| 1.07 | ||
| $7M | ||
| Revenue, 1Y Change | +99.06% | |
| -$1.20 | ||
| EPS, 1Y Change | +37.96% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | TPIV | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.20 | ||
| EPS Estimate | N/A | -$0.94 |
| EPS Est. Change | N/A | +21.76% |
| $6.59M | ||
| Revenue Estimate | N/A | $3.10M |
| Revenue Est. Change | N/A | -53.02% |
| $1.45 | ||
| Price Target | - | $8.00 |
| Price Tgt. Change | - | +451.72% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.40 | -$1.93 | +43.35% | |
| -$0.97 | -$1.20 | -23.20% | |
| -$0.94 | N/A | +21.76% | |
| -$0.79 | N/A | +33.89% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $3.31M | - | |
| $8.32M | $6.59M | -20.79% | |
| $3.10M | N/A | -53.02% | |
| $2.70M | N/A | -59.11% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -15.70% | ||
| -38.56% | ||
| +1.86% | ||
| -6.91% | ||
| +99.06% | ||
| +430.81% | ||
| +37.96% | ||
| +78.17% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.45 | ||
| $1.31 | ||
| SMA 200 vs Price | -9.66% | |
| $1.63 | ||
| SMA 50 vs Price | +12.26% | |
| 1.07 | ||
| $0.17 | ||
| 41.48 | ||
| 90.39% | ||
| 104.41% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $6.59M | ||
| -$1.20 | ||
| $0.00 | ||
| 0.00% | ||
| -$11.12M | ||
| -168.69% | ||
| -$10.73M | ||
| -162.82% | ||
| -$11.12M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 6.36 | ||
| 6.36 | ||
| - | ||
| 1 | ||
| -25.52 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 4.00 | ||
| 1.02 | ||
| 0.01 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $18.56M | ||
| $19.19M | ||
| $22.02M | ||
| $22.02M | ||
| $3.46M | ||
| $3.46M | ||
| $0.00 | ||
| $0.00 | ||
| $1.07M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $17.32M | ||
| $11.12M | ||
| - | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $50.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$10.91M | ||
| $0.00 | ||
| $14.99M | ||
| $0.00 | ||
| -$10.91M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | ||
| WBB Securities | → | |
| Canaccord Genuity | ||
| Ladenburg Thalmann | ||
| Roth Capital | → | |
| Piper Sandler | ||
| Cantor Fitzgerald | ||
| Cantor Fitzgerald | ||
| Piper Sandler | → | |
| Piper Jaffray |
Analyst sentiment
Institutional ownership
Screeners with MRKR
FAQ
What is the ticker symbol for Marker Therapeutics, Inc.?
The ticker symbol for Marker Therapeutics, Inc. is NASDAQ:MRKR
Does Marker Therapeutics, Inc. pay dividends?
No, Marker Therapeutics, Inc. does not pay dividends
What sector is Marker Therapeutics, Inc. in?
Marker Therapeutics, Inc. is in the Healthcare sector
What industry is Marker Therapeutics, Inc. in?
Marker Therapeutics, Inc. is in the Biotechnology industry
What country is Marker Therapeutics, Inc. based in?
Marker Therapeutics, Inc. is headquartered in United States
When did Marker Therapeutics, Inc. go public?
Marker Therapeutics, Inc. initial public offering (IPO) was on July 16, 2002
Is Marker Therapeutics, Inc. in the S&P 500?
No, Marker Therapeutics, Inc. is not included in the S&P 500 index
Is Marker Therapeutics, Inc. in the NASDAQ 100?
No, Marker Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Marker Therapeutics, Inc. in the Dow Jones?
No, Marker Therapeutics, Inc. is not included in the Dow Jones index
When was Marker Therapeutics, Inc. last earnings report?
Marker Therapeutics, Inc.'s most recent earnings report was on November 14, 2025
When does Marker Therapeutics, Inc. report earnings?
The date for Marker Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- MRKR Official Website markertherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1094038/000110465925111502/0001104659-25-111502-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1094038/000141057825000549/0001410578-25-000549-index.htm
- MRKR Profile on Yahoo Finance finance.yahoo.com/quote/MRKR
- MRKR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrkr